Clopidogrel (as bisulfate) …… 75 mg

COMPOSITION :
Each film-coated tablet contains:
Clopidogrel (as bisulfate) …… 75 mg

INDICATIONS :
Clopidogrel is indicated for the reduction of atherothrombotic events as follows:

Recent Myocardial Indarction, Recent Stroke or Established Peripheral Arterial Disease
For patients with a history of recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular deaths.

Acute Coronary Syndrome
For patients with acute coronary syndrome (unstable angina/non-Q-wave
MI) including patients who are to be managed medically and those who are
to be managed with percutaneous coronary intervention (with or without stent)
or CABG, clopidogrel has been shown to decrease the rate of a combined endpoint of cardiovascular death, MI, or stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia

DOSAGE AND ADMINISTRATION :

Recent MI, recent stroke or established PAD
The recommended dose is 75 mg once daily.

Acute Coronary Syndrome
Clopidogrel should be initiated with a single 300 mg loading dose and then continued at 75 mg once daily. Aspirin (75-325 mg) once daily should be initiated and continued in combination with clopidogrel.

CONTRAINDICATIONS :

* Hypersensitivity to the drug
* Active pathological bleeding such as peptic ulcer or intracranial hemorrhage


PACKAGING INFORMATION :

Clopidogrel ...........Strip of 10 tablets

Larger View